Former CEO and current Altasciences Executive Chairman Chris Perkin sits down with newly appointed CEO Marie-Hélène Raigneau for a candid conversation reflecting on the lessons learned in drug development, the leadership qualities required in today’s evolving CRO landscape, and the path forward for Altasciences under her leadership. And of course, it wouldn’t be Beer Chats without a few laughs along the way! Get to know whether Marie-Hélène prefers dogs or cats, why Mötley Crüe’s “Kickstart My Heart” holds a special meaning for her, and her own answer to the critical question she liked to ask job candidates earlier in her career: “What animal would you be?” Altasciences is an integrated drug development solution company, offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. From lead candidate selection to proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing and analytical services. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements.

Step Inside Altasciences’ Bioanalytical Facility in Seattle, Washington
205 views

A Day In the Life of A Clinical Trial Participant
64 views

TIDES 2026—Hybridization LC-MS/MS: A Selective Solution for PMO and PPMO Bioanalysis
9 views

Accelerate Your Data With Our Co-located Clinic and Lab │Altasciences
11 views

Kansas Clinical Facility - Mini Virtual Tour
17 views

Webinar—Skin in the Game? Get Safety Right: Nonclinical Study Requirements for Dermal Therapies
6 views